Company · Private
Loyal
Veterinary medicine company developing the first drugs intended to extend healthy lifespan in dogs, led by LOY-002 for senior dogs.
Listing
Private
Ticker
—
Headquarters
San Francisco, US
Founded
2019
Technology
Canine longevity therapeutics
Category
Longevity thesis
Dogs share human environments and age-related diseases; a validated canine longevity drug would be both a product and the strongest large-animal proof point for the field.
Programmes
- LOY-002Phase 3
Healthy lifespan extension in senior dogs
- LOY-001Phase 3
Lifespan extension in large and giant breeds
Reference information for research context only. It is not a rating, a valuation or investment advice. Published developments appear in the News archive.